Reading: The updated Pharmaceutical Model Licence for E-journals: a continuing collaboration between ...

Download

A- A+
Alt. Display

Articles

The updated Pharmaceutical Model Licence for E-journals: a continuing collaboration between publishers and the pharmaceutical industry

Authors:

Philip J Ditchfield ,

GlaxoSmithKline Research & Development Limited
X close

Henning P Nielsen

Novo Nordisk A/S
X close

Abstract

Seven years have passed since the International Association of Scientific,Technical and Medical Publishers (STM) and the Pharma Documen- tation Ring (P-D-R) first agreed on a Draft Model Licence.The original not only became the foundation of licensing e-journals within the pharmaceutical industry, it also created a better, mutual understanding between publishers and pharmaceutical companies.The P-D-R and publisher copyright taskforce have updated the original licence, which now better reflects advances in technology and business practices.This article discusses the development of the new licence, the rationale behind the changes, and the benefits to the pharma- ceutical industry.

DOI: https://doi.org/10.1629/2125
How to Cite: Ditchfield, P.J. and Nielsen, H.P., 2008. The updated Pharmaceutical Model Licence for E-journals: a continuing collaboration between publishers and the pharmaceutical industry. Serials, 21(1), pp.25–29. DOI: http://doi.org/10.1629/2125
Published on 01 Mar 2008.
Peer Reviewed

Downloads

  • PDF (EN)

    comments powered by Disqus